PETQ / PetIQ, Inc. - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

PetIQ, Inc.
US ˙ NasdaqGS ˙ US71639T1060
HINDI NA ACTIVE ANG SIMBONG ITO

Mga Batayang Estadistika
LEI 549300GROACFGKVYOX14
CIK 1668673
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to PetIQ, Inc.
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
November 14, 2024 SC 13G/A

PETQ / PetIQ, Inc. / GLAZER CAPITAL, LLC Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 PetIQ, Inc. (Name of Issuer) Class A Common Stock, $0.001 par value per share (Title of Class of Securities) 71639T106 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to wh

November 4, 2024 15-12G

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 001-38163 PetIQ, Inc. (Exact name of registrant as specified in its charter)

October 25, 2024 EX-99.1

PetIQ, Inc. Announces Successful Completion of Acquisition by Bansk Group

Exhibit 99.1 PetIQ, Inc. Announces Successful Completion of Acquisition by Bansk Group EAGLE, Idaho and NEW YORK, New York – October 25, 2024 (GLOBE NEWSWIRE) - PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication, health and wellness company, today announced the successful completion of its acquisition by Bansk Group, a consumer-focused private investment firm dedicated

October 25, 2024 S-8 POS

As filed with the Securities and Exchange Commission on October 25, 2024

As filed with the Securities and Exchange Commission on October 25, 2024 Registration No.

October 25, 2024 EX-3.2

  SECOND AMENDED AND RESTATED

  Exhibit 3.2   SECOND AMENDED AND RESTATED   BYLAWS   OF   PETIQ, INC.   * * * * *  Article 1 Offices   Section 1.01. Registered Office. The registered office of PetIQ, Inc. (the “Corporation”) shall be in the City of Wilmington, County of New Castle, State of Delaware.   Section 1.02. Other Offices. The Corporation may also have offices at such other places both within and without the State of D

October 25, 2024 EX-4.1

PETIQ, INC. COMPUTERSHARE TRUST COMPANY, N.A. (as successor to WELLS FARGO BANK, NATIONAL ASSOCIATION, as Trustee), as Trustee FIRST SUPPLEMENTAL INDENTURE Dated as of October 25, 2024 4.00% Convertible Senior Notes due 2026

Exhibit 4.1 PETIQ, INC. AND COMPUTERSHARE TRUST COMPANY, N.A. (as successor to WELLS FARGO BANK, NATIONAL ASSOCIATION, as Trustee), as Trustee FIRST SUPPLEMENTAL INDENTURE Dated as of October 25, 2024 4.00% Convertible Senior Notes due 2026 FIRST SUPPLEMENTAL INDENTURE, dated as of October 25, 2024 (this “Supplemental Indenture”), between PetIQ, Inc., a Delaware corporation (the “Company”), as iss

October 25, 2024 S-8 POS

As filed with the Securities and Exchange Commission on October 25, 2024

As filed with the Securities and Exchange Commission on October 25, 2024 Registration No.

October 25, 2024 8-K

Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Material Modification to Rights of Security Holders, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 25, 2024 PetIQ, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-38163 35-2554312 (State or Other Jurisdiction of Incorporation) (Commission File Numbe

October 25, 2024 S-8 POS

As filed with the Securities and Exchange Commission on October 25, 2024

As filed with the Securities and Exchange Commission on October 25, 2024 Registration No.

October 25, 2024 S-8 POS

As filed with the Securities and Exchange Commission on October 25, 2024

As filed with the Securities and Exchange Commission on October 25, 2024 Registration No.

October 25, 2024 EX-3.1

THIRD AMENDED AND RESTATED CERTIFICATE OF INCORPORATION PETIQ, INC. October 25, 2024

Exhibit 3.1 THIRD AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF PETIQ, INC. October 25, 2024 FIRST: The name of the corporation is PetIQ, Inc. (the “Corporation”). SECOND: The address of its registered office in the State of Delaware is Corporation Service Company, 251 Little Falls Drive, City of Wilmington, County of New Castle, Delaware 19808. The name of its registered agent at such addr

October 22, 2024 EX-99.1

PetIQ, Inc. Announces Results of Special Meeting of Stockholders Reports Merger Agreement with Bansk Group Approved by Stockholders and Anticipates a Closing Date of October 25, 2024

Exhibit 99.1 PetIQ, Inc. Announces Results of Special Meeting of Stockholders Reports Merger Agreement with Bansk Group Approved by Stockholders and Anticipates a Closing Date of October 25, 2024 EAGLE, Idaho – October 22, 2024 (GLOBE NEWSWIRE) - PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication, health and wellness company, announced today that at its virtual Special

October 22, 2024 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 22, 2024 PetIQ, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-38163 35-2554312 (State or Other Jurisdiction of Incorporation) (Commission File Numbe

October 11, 2024 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin

October 11, 2024 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 11, 2024 PetIQ, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-38163 35-2554312 (State or Other Jurisdiction of Incorporation) (Commission File Numbe

September 17, 2024 DEFM14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act Of 1934

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act Of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defi

September 16, 2024 DEFM14A

DEFM14A

September 6, 2024 PREM14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act Of 1934

TABLE OF CONTENTS PRELIMINARY PROXY STATEMENT — SUBJECT TO COMPLETION, DATED SEPTEMBER 6, 2024 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

September 6, 2024 EX-FILING FEES

CALCULATION OF FILING FEE TABLES Schedule 14A (Form Type) PetIQ, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Transaction Valuation

Exhibit 107 CALCULATION OF FILING FEE TABLES Schedule 14A (Form Type) PetIQ, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Transaction Valuation Proposed Maximum Aggregate Value of Transaction Fee Rate Amount of Filing Fee Fees to be Paid $ 1,138,543,009.50 .00014760 $ 168,049 Fees Previously Paid $ 0 $ 0 Total Transaction Valuation $ 1,138,543,009.50 Total Fees Due for Fili

August 30, 2024 SC 13G

PETQ / PetIQ, Inc. / GLAZER CAPITAL, LLC Passive Investment

SC 13G 1 petq20240822.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 PetIQ, Inc. (Name of Issuer) Class A Common Stock, $0.001 par value per share (Title of Class of Securities) 71639T106 (CUSIP Number) August 22, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate th

August 13, 2024 CORRESP

August 13, 2024

August 13, 2024 VIA EDGAR Stephen Kim Doug Jones Division of Corporation Finance Office of Trade & Services United States Securities and Exchange Commission 100 F Street, NE Washington, D.

August 8, 2024 EX-10.1

PetIQ, Inc. 2024 Omnibus Incentive Plan

PETIQ, INC. 2024 OMNIBUS INCENTIVE PLAN Section 1. General. The name of the Plan is the PetIQ, Inc. 2024 Omnibus Incentive Plan (the “Plan”). The Plan intends to: (i) encourage the profitability and growth of the Company through short-term and long-term incentives that are consistent with the Company’s objectives; (ii) give Participants an incentive for excellence in individual performance; (iii)

August 8, 2024 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 ¨ TRANSITION REPORT PURSUANT TO S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38163 PetIQ, Inc. (Exact name

August 7, 2024 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 7, 2024 PetIQ, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-38163 35-2554312 (State or Other Jurisdiction of Incorporation) (Commission File Number)

August 7, 2024 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 7, 2024 PETIQ, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-38163 (Commission File Number) 35-2554312

August 7, 2024 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant x Filed by a party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy State

August 7, 2024 EX-99.1

PetIQ, Inc. Enters into Definitive Agreement to be Acquired by Bansk Group PetIQ Stockholders to Receive $31.00 Per Share in an All-Cash Transaction Valued at Approximately $1.5 Billion

Exhibit 99.1 PetIQ, Inc. Enters into Definitive Agreement to be Acquired by Bansk Group PetIQ Stockholders to Receive $31.00 Per Share in an All-Cash Transaction Valued at Approximately $1.5 Billion EAGLE, Idaho, and NEW YORK, New York, August 7, 2024 (GLOBE NEWSWIRE) - PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication, health and wellness company, and Bansk Group (“B

August 7, 2024 EX-99.1

PetIQ, Inc. Reports Second Quarter 2024 Financial Results Generates Record Second Quarter 2024 Net Sales and Net Income Record Adjusted EBITDA of $39.0 Million Exceeds Company's Second Quarter 2024 Guidance PetIQ and Bansk Group Sign Definitive Merge

PetIQ, Inc. Reports Second Quarter 2024 Financial Results Generates Record Second Quarter 2024 Net Sales and Net Income Record Adjusted EBITDA of $39.0 Million Exceeds Company's Second Quarter 2024 Guidance PetIQ and Bansk Group Sign Definitive Merger Agreement EAGLE, Idaho – August 7, 2024 (GLOBE NEWSWIRE) - PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication, product

August 7, 2024 EX-2.1

Agreement and Plan of Merger, dated August 7, 2024 among Gula Buyer Inc., Gula Merger Sub Inc. and PetIQ, Inc.

Exhibit 2.1 Execution Version AGREEMENT AND PLAN OF MERGER by and among PetIQ, Inc. Gula Buyer Inc. and Gula Merger Sub Inc. Dated as of August 7, 2024 TABLE OF CONTENTS Page ARTICLE I THE MERGER 2 Section 1.1 Merger of Merger Sub into the Company 2 Section 1.2 Effect of the Merger 3 Section 1.3 Closing; Effective Time 3 Section 1.4 Certificate of Incorporation and Bylaws; Directors and Officers 3

August 7, 2024 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin

August 7, 2024 EX-10.1

Second Amended and Restated Executive Employment Agreement, dated August 7, 2024, by and between PetIQ, Inc. and McCord Christensen.

Exhibit 10.1 EXECUTION SECOND amended and restated EXECUTIVE Employment Agreement This Second Amended and Restated Executive Employment Agreement (“Agreement”) is by and between McCord Christensen (“Executive”) and PetIQ, Inc. (the “Company”). Whereas, Executive has been employed by the Company as its Chief Executive Officer pursuant to that Amended and Restated Employment and Non-Competition Agre

June 12, 2024 8-K

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 7, 2024 PETIQ INC. (Exact Name of Registrant as Specified in Charter) Delaware 001-38163 35-2554312 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS E

May 9, 2024 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38163 PetIQ, Inc. (Exact name

May 8, 2024 EX-99.1

PetIQ, Inc. Reports First Quarter 2024 Financial Results Reports Record First Quarter 2024 Net Sales of $308.4 Million Achieves Record First Quarter Net Income Record Adjusted EBITDA Exceeds Company's First Quarter 2024 Guidance Raises Full Year 2024

PetIQ, Inc. Reports First Quarter 2024 Financial Results Reports Record First Quarter 2024 Net Sales of $308.4 Million Achieves Record First Quarter Net Income Record Adjusted EBITDA Exceeds Company's First Quarter 2024 Guidance Raises Full Year 2024 Outlook EAGLE, Idaho – May 8, 2024 (GLOBE NEWSWIRE) - PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication, product and we

May 8, 2024 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2024 PETIQ, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-38163 (Commission File Number) 35-2554312 (I

April 19, 2024 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin

April 19, 2024 DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.           )

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.           ) Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted

February 29, 2024 EX-10.20

Form of Non-Employee Director Restricted Stock Unit Agreement pursuant to the Amended and Restated PetIQ, Inc. 2017 Omnibus Incentive Plan

PETIQ, INC. AMENDED AND RESTATED 2017 OMNIBUS INCENTIVE PLAN RESTRICTED STOCK UNIT AGREEMENT FOR NON-EMPLOYEE DIRECTORS THIS RESTRICTED STOCK UNIT AGREEMENT (this “Agreement”) is made effective as of [[GRANTDATE]] (the “Grant Date”) by and between PetIQ, Inc., a Delaware corporation (the “Company”), and [[FIRSTNAME]] [[LASTNAME]] (the “Participant”), pursuant to the PetIQ, Inc. Amended and Restate

February 29, 2024 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38163 PetIQ, Inc. (Exact name of r

February 29, 2024 EX-10.18

Conformed ABL Credit and Guaranty Agreement, dated April 1, 2021, among PetIQ Holdings LLC, PetIQ LLC, the guarantor subsidiaries party thereto, the lenders party thereto and KeyBank National Association, as administrative and collateral agent.

Conformed through First Amendment, dated February 3, 2023, and effective as of February 3, 2023 ===================================================================== Published Transaction CUSIP Number: 71639UAC7 Revolving Facility CUSIP Number: 71639UAD5 ABL CREDIT AND GUARANTY AGREEMENT dated as of April 13, 2021, among PETIQ HOLDINGS, LLC, PETIQ, LLC, CERTAIN SUBSIDIARIES OF PETIQ HOLDINGS, LLC, as Guarantor Subsidiaries, THE LENDERS PARTY HERETO and KEYBANK NATIONAL ASSOCIATION, as Administrative Agent and Collateral Agent KEYBANC CAPITAL MARKETS INC.

February 29, 2024 EX-21.1

List of Subsidiaries of PetIQ Inc.

Exhibit 21.1 List of Subsidiaries of PetIQ Inc. Name of Subsidiary State or Country of Incorporation or Organization ECP IV TS Investor Co. Delaware PetIQ Holdings, LLC Delaware PetIQ, LLC Idaho PetIQ, LLC Florida Mark and Chappell Limited United Kingdom PetIQ MFG, LLC Utah Community Veterinary Clinics, LLC dba VIP Petcare Delaware Sergeant’s Pet Care Products, LLC Michigan Velcera, LLC Delaware

February 29, 2024 EX-97.1

Incentive Compensation Recoupment Policy

Exhibit 97.1 PetIQ, Inc. Incentive Compensation Recoupment Policy 1.Introduction The Compensation Committee (the “Compensation Committee”) of the Board of Directors (the “Board”) of PetIQ, Inc., a Delaware corporation (the “Company”), has determined that it is in the best interests of the Company and its stockholders to adopt this Incentive Compensation Recoupment Policy (this “Policy”) providing

February 29, 2024 EX-10.19

Form of Restricted Stock Unit Agreement pursuant to the Amended and Restated PetIQ, Inc. 2017 Omnibus Incentive Plan

PETIQ, INC. AMENDED AND RESTATED 2017 OMNIBUS INCENTIVE PLAN RESTRICTED STOCK UNIT AGREEMENT THIS RESTRICTED STOCK UNIT AGREEMENT (this “Agreement”) is made effective as of [[GRANTDATE]] (the “Grant Date”) by and between PetIQ, Inc., a Delaware corporation (the “Company”), and [[FIRSTNAME]] [[LASTNAME]] (the “Participant”), pursuant to the PetIQ, Inc. Amended and Restated 2017 Omnibus Incentive Pl

February 29, 2024 EX-10.21

Employment Agreement, dated April 26, 2022, between PetIQ, LLC and John Pearson, as amended on April 26, 2022

Exhibit 10.21 AMENDED AND RESTATED EMPLOYMENT AND NON-COMPETITION AGREEMENT AMENDED AND RESTATED EMPLOYMENT AND NON-COMPETITION AGREEMENT (this “Agreement”) dated as of February 27, 2024, between PetIQ, LLC, an Idaho limited liability company (the “Company”), and John Pearson (the “Employee”). WHEREAS, the Company and the Employee desire to enter into this Agreement to amend and restate the Employ

February 28, 2024 EX-99.1

PetIQ, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results Record Full Year 2023 Net Sales Increase 19.6% Year-Over-Year to Over $1.1 Billion Adjusted EBITDA Exceeds Company's Full Year 2023 Guidance Reports Highest Annual Cash from Oper

PetIQ, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results Record Full Year 2023 Net Sales Increase 19.6% Year-Over-Year to Over $1.1 Billion Adjusted EBITDA Exceeds Company's Full Year 2023 Guidance Reports Highest Annual Cash from Operations in the Company's History of $61.9 Million Provides First Quarter 2024 and Full Year 2024 Outlook EAGLE, Idaho – February 28, 2024 (GLOBE NEWSWI

February 28, 2024 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 28, 2024 PETIQ, INC. (Ex

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 28, 2024 PETIQ, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-38163 (Commission File Number) 35-2554

February 13, 2024 SC 13G/A

PETQ / PetIQ, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SC 13G/A 1 tv01690-petiqincclassa.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 1)* Name of issuer: PetIQ, Inc. Class A Title of Class of Securities: Common Stock CUSIP Number: 71639T106 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to designate

February 13, 2024 SC 13G/A

PETQ / PetIQ, Inc. / Applied Fundamental Research, LLC - SCHEDULE 13G/A Passive Investment

SC 13G/A 1 schedule13g.htm SCHEDULE 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* PetIQ, Inc (Name of Issuer) Class A Common Stock, $0.001 par value (Title of Class of Securities) 71639T106 (CUSIP Number) December 31, 2023 (Date of Event which Requires Filing of this Statement) Check the appro

November 7, 2023 EX-99.1

PetIQ, Inc. Reports Third Quarter 2023 Financial Results Record Third Quarter 2023 Net Sales Increase 32% to $277.0 Million Net Sales and Adjusted EBITDA Exceed Company's Third Quarter 2023 Guidance Highest Year-to-Date Cash from Operations in the Co

PetIQ, Inc. Reports Third Quarter 2023 Financial Results Record Third Quarter 2023 Net Sales Increase 32% to $277.0 Million Net Sales and Adjusted EBITDA Exceed Company's Third Quarter 2023 Guidance Highest Year-to-Date Cash from Operations in the Company's History of $64.7 Million Announces Services Segment Optimization Raises 2023 Annual Outlook EAGLE, Idaho – November 7, 2023 (GLOBE NEWSWIRE) -

November 7, 2023 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38163 PetIQ, Inc. (Exact

November 7, 2023 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 7, 2023 PETIQ, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-38163 (Commission File Number) 35-25543

August 9, 2023 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38163 PetIQ,

August 8, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 8, 2023 PETIQ, INC. (Exact

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 8, 2023 PETIQ, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-38163 (Commission File Number) 35-2554312

August 8, 2023 EX-99.1

PetIQ, Inc. Reports Second Quarter 2023 Financial Results Record Second Quarter 2023 Net Sales Increase 25% to $314.5 Million Net Sales and Adjusted EBITDA Exceeds Company's Second Quarter 2023 Guidance Record Second Quarter Cash from Operations of $

PetIQ, Inc. Reports Second Quarter 2023 Financial Results Record Second Quarter 2023 Net Sales Increase 25% to $314.5 Million Net Sales and Adjusted EBITDA Exceeds Company's Second Quarter 2023 Guidance Record Second Quarter Cash from Operations of $57.7 Million Raises 2023 Annual Outlook EAGLE, Idaho – August 8, 2023 (GLOBE NEWSWIRE) - PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a lead

August 3, 2023 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 2, 2023 PETIQ INC. (Exact Name of Registrant as Specified in Charter) Delaware 001-38163 35-2554312 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS

June 26, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 26, 2023 PETIQ, INC. (Exact

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 26, 2023 PETIQ, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-38163 (Commission File Number) 35-2554312

June 22, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 21, 2023 PETIQ INC. (Exact N

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 21, 2023 PETIQ INC. (Exact Name of Registrant as Specified in Charter) Delaware 001-38163 35-2554312 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS

May 31, 2023 EX-10.1

Amendment No. 1, dated May 25, 2023, among PetIQ Holdings, LLC, PetIQ, LLC, the guarantor subsidiaries party thereto, the lenders party thereto and Jefferies Finance LLC, as administrative and collateral agent.

Exhibit 10.1 EXECUTION VERSION AMENDMENT NO. 1, dated as of May 25, 2023 (this “Amendment”), to the TERM CREDIT AND GUARANTY AGREEMENT dated as of April 13, 2021 (as amended, restated, supplemented or otherwise modified prior to the date hereof, the “Existing Credit Agreement”, and as amended pursuant to this Amendment, the “Amended Credit Agreement”), among PETIQ HOLDINGS, LLC, a Delaware limited

May 31, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 25, 2023 PETIQ, INC. (Exact N

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 25, 2023 PETIQ, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-38163 35-2554312 (State or other jurisdiction of Incorporation) (Commission File Number) (

May 10, 2023 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38163 PetIQ

May 9, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 9, 2023 PETIQ, INC. (Exact na

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 9, 2023 PETIQ, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-38163 (Commission File Number) 35-2554312 (I

May 9, 2023 EX-99.1

PetIQ, Inc. Reports First Quarter 2023 Financial Results Reports First Quarter 2023 Net Sales of $290.5 Million Achieves Record Quarterly Net Income Record Quarterly Adjusted EBITDA Exceeds Company's First Quarter 2023 Guidance Reiterates 2023 Annual

PetIQ, Inc. Reports First Quarter 2023 Financial Results Reports First Quarter 2023 Net Sales of $290.5 Million Achieves Record Quarterly Net Income Record Quarterly Adjusted EBITDA Exceeds Company's First Quarter 2023 Guidance Reiterates 2023 Annual Outlook EAGLE, Idaho – May 9, 2023 (GLOBE NEWSWIRE) - PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness co

April 28, 2023 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin

April 28, 2023 DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.      )

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.      ) Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Ru

March 1, 2023 EX-10.17

Conformed ABL Credit and Guaranty Agreement, dated April 1, 2021, among PetIQ Holdings LLC, PetIQ LLC, the guarantor subsidiaries party thereto, the lenders party thereto and KeyBank National Association, as administrative and collateral agent.

Conformed through First Amendment, dated February 3, 2023, and effective as of February 3, 2023 ===================================================================== Published Transaction CUSIP Number: 71639UAC7 Revolving Facility CUSIP Number: 71639UAD5 ABL CREDIT AND GUARANTY AGREEMENT dated as of April 13, 2021, among PETIQ HOLDINGS, LLC, PETIQ, LLC, CERTAIN SUBSIDIARIES OF PETIQ HOLDINGS, LLC, as Guarantor Subsidiaries, THE LENDERS PARTY HERETO and KEYBANK NATIONAL ASSOCIATION, as Administrative Agent and Collateral Agent KEYBANC CAPITAL MARKETS INC.

March 1, 2023 EX-10.18

Form of Restricted Stock Unit Agreement pursuant to the Amended and Restated PetIQ, Inc. 2017 Omnibus Incentive Plan

PETIQ, INC. AMENDED AND RESTATED 2017 OMNIBUS INCENTIVE PLAN RESTRICTED STOCK UNIT AGREEMENT THIS RESTRICTED STOCK UNIT AGREEMENT (this “Agreement”) is made effective as of [[GRANTDATE]] (the “Grant Date”) by and between PetIQ, Inc., a Delaware corporation (the “Company”), and [[FIRSTNAME]] [[LASTNAME]] (the “Participant”), pursuant to the PetIQ, Inc. Amended and Restated 2017 Omnibus Incentive Pl

March 1, 2023 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38163 PetIQ, Inc

March 1, 2023 EX-21.1

List of Subsidiaries of PetIQ Inc.

Exhibit 21.1 List of Subsidiaries of PetIQ Inc. Name of Subsidiary State or Country of Incorporation or Organization ECP IV TS Investor Co. Delaware PetIQ Holdings, LLC Delaware PetIQ, LLC Idaho PetIQ, LLC Florida TruRX, LLC Idaho Tru Prodigy, LLC Texas M&C USA, LLC Delaware Mark and Chappell Limited United Kingdom Mark and Chappell (Ireland) Limited Ireland Prodex D.O.O. Slovenia PetIQ MFG, LLC U

March 1, 2023 EX-10.19

Form of Non-Employee Director Restricted Stock Unit Agreement pursuant to the Amended and Restated PetIQ, Inc. 2017 Omnibus Incentive Plan

PETIQ, INC. AMENDED AND RESTATED 2017 OMNIBUS INCENTIVE PLAN RESTRICTED STOCK UNIT AGREEMENT FOR NON-EMPLOYEE DIRECTORS THIS RESTRICTED STOCK UNIT AGREEMENT (this “Agreement”) is made effective as of [[GRANTDATE]] (the “Grant Date”) by and between PetIQ, Inc., a Delaware corporation (the “Company”), and [[FIRSTNAME]] [[LASTNAME]] (the “Participant”), pursuant to the PetIQ, Inc. Amended and Restate

February 28, 2023 EX-99.1

PetIQ, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results Full Year 2022 Net Sales and Adjusted EBITDA In-Line with Company Guidance Updates Adjusted EBITDA Methodology Reports Record Annual Cash from Operations of $48.0 Million Complet

PetIQ, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results Full Year 2022 Net Sales and Adjusted EBITDA In-Line with Company Guidance Updates Adjusted EBITDA Methodology Reports Record Annual Cash from Operations of $48.0 Million Completes Complementary, Margin Accretive Acquisition of Rocco & Roxie Provides First Quarter 2023 and Full Year 2023 Outlook EAGLE, Idaho – February 28, 202

February 28, 2023 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 28, 2023 PETIQ, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-38163 (Commission File Number) 35-2554

February 14, 2023 SC 13G/A

PETQ / PetIQ Inc / MACQUARIE GROUP LTD - SC 13G/A Passive Investment

SC 13G/A 1 d395966dsc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* PetIQ Inc. (Name of Issuer) Common Shares (Title of Class of Securities) 71639T106 (CUSIP Number) December 30, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the

February 14, 2023 EX-99.B

Page 12 of 12

EX-99.B 3 d395966dex99b.htm EX-99.B Exhibit 99.B EXHIBIT B Powers of Attorney for Macquarie Group Limited and Macquarie Bank Limited incorporated by reference to 13G filings made by Macquarie Group Limited and Macquarie Bank Limited on May 25, 2021. Page 12 of 12

February 14, 2023 EX-99.A

Page 8 of 12

EX-99.A 2 d395966dex99a.htm EX-99.A EXHIBIT A AGREEMENT TO FILE JOINT ACQUISITION STATEMENTS AGREEMENT made this 2nd day of FEBRUARY, 2021 by and between Delaware Funds® by Macquarie listed on Annex A hereto, Macquarie Investment Management Business Trust, Macquarie Management Holdings, Inc, and the Macquarie Parties listed on Annex B hereto (collectively referred to as the “parties”). WHEREAS, th

February 13, 2023 SC 13G/A

PETQ / PetIQ Inc / Applied Fundamental Research, LLC - SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* PetIQ, Inc (Name of Issuer) Class A Common Stock, $0.001 par value (Title of Class of Securities) 71639T106 (CUSIP Number) December 31, 2022 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant

February 10, 2023 8-K/A

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Amendment No. 1 To CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported):February 10, 2023 (February 3, 2023) PETIQ, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001

February 10, 2023 EX-10.1

First Amendment Agreement, dated February 3, 2023, among PetIQ Holdings, LLC, PetIQ, LLC, the guarantor subsidiaries party thereto, the lenders party thereto and KeyBank National Association, as administrative and collateral agent.

FIRST AMENDMENT AGREEMENT This FIRST AMENDMENT AGREEMENT (this “Amendment”) is made as of the 3rd day of February, 2023 among: (a) PETIQ HOLDINGS, LLC, a Delaware limited liability company (“Holdings”); (b) PETIQ, LLC, an Idaho limited liability company (the “Borrower”); (c) the Guarantor Subsidiaries, as defined in the Credit Agreement, as hereinafter defined; (d) the Lenders, as defined in the Credit Agreement, as hereinafter defined; and (e) KEYBANK NATIONAL ASSOCIATION, a national banking association, as the administrative agent for the Lenders under the Credit Agreement (the “Administrative Agent”).

February 9, 2023 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 3, 2023 PETIQ, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-38163 (Commission File Number) 35-25543

February 9, 2023 SC 13G

PETQ / PetIQ Inc / VANGUARD GROUP INC - SCHEDULE 13G Passive Investment

SC 13G 1 tv01661-petiqincclassa.htm SCHEDULE 13G SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 Name of issuer: PetIQ Inc. Class A Title of Class of Securities: Common Stock CUSIP Number: 71639T106 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designate the rule pursuant to whi

February 9, 2023 EX-10.1

First Amendment Agreement, dated February 3, 2023, among PetIQ Holdings, LLC, PetIQ, LLC, the guarantor subsidiaries party thereto, the lenders party thereto and KeyBank National Association, as administrative and collateral agent.

FIRST AMENDMENT AGREEMENT This FIRST AMENDMENT AGREEMENT (this “Amendment”) is made as of the 3rd day of February, 2023 among: (a) PETIQ HOLDINGS, LLC, a Delaware limited liability company (“Holdings”); (b) PETIQ, LLC, an Idaho limited liability company (the “Borrower”); (c) the Guarantor Subsidiaries, as defined in the Credit Agreement, as hereinafter defined; (d) the Lenders, as defined in the Credit Agreement, as hereinafter defined; and (e) KEYBANK NATIONAL ASSOCIATION, a national banking association, as the administrative agent for the Lenders under the Credit Agreement (the “Administrative Agent”).

November 9, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38163 P

November 9, 2022 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 9, 2022 PETIQ, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-38163 (Commission File Number) 35-25543

November 9, 2022 EX-99.1

PetIQ, Inc. Reports Third Quarter 2022 Financial Results Third Quarter 2022 Net Sales of Approximately $210 Million at the High-End of Guidance Adjusted EBITDA Exceeds Company's Third Quarter Guidance Reports Record Quarterly Cash from Operations of

PetIQ, Inc. Reports Third Quarter 2022 Financial Results Third Quarter 2022 Net Sales of Approximately $210 Million at the High-End of Guidance Adjusted EBITDA Exceeds Company's Third Quarter Guidance Reports Record Quarterly Cash from Operations of $64.5 Million Raises 2022 Annual Adjusted EBITDA Outlook EAGLE, Idaho ? November 9, 2022 (GLOBE NEWSWIRE) - PetIQ, Inc. (?PetIQ? or the ?Company?) (Na

October 31, 2022 EX-3.1

Amended and Restated Bylaws of PetIQ, Inc.

Exhibit 3.1 ARTICLE?1 Stockholders 3 1.1??? Place of Meetings 3 1.2?? Annual Meetings 3 1.3 Special Meetings 3 1.4???? Notice of Meetings 3 1.5 Adjournments 3 1.6?? Quorum 4 1.7?? Organization 4 1.8 Voting; Proxies 4 1.9 Fixing Date for Determination of Stockholders of Record 5 1.10? List of Stockholders Entitled to Vote 5 1.11???? Notice of Stockholder Business; Nominations 6 ARTICLE?2 Board of D

October 31, 2022 8-K

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 26, 2022 PETIQ, INC. (Exact name of registrant as specified in its charter) Delaware 001-38163 35-2554312 (State or other jurisdiction of incorporation) (Commission File Numbe

October 19, 2022 CORRESP

* * *

CORRESP 1 filename1.htm VIA EDGAR October 19, 2022 Division of Corporation Finance Office of Trade & Services United States Securities and Exchange Commission 100 F Street NE Washington, DC 20549 Attn:       Robert Shapiro Abe Friedman Re:          PetIQ, Inc. Form 10-K for Fiscal Year Ended December 31, 2021 Filed March 1, 2021 Form 8-K Furnished May 4, 2022 File No. 001-38163 Dear Messrs. Shapir

October 14, 2022 CORRESP

* * *

VIA EDGAR October 14, 2022 Division of Corporation Finance Office of Trade & Services United States Securities and Exchange Commission 100 F Street NE Washington, DC 20549 Attn: Robert Shapiro Abe Friedman Re: PetIQ, Inc.

October 7, 2022 CORRESP

* * *

CORRESP 1 filename1.htm VIA EDGAR October 7, 2022 Division of Corporation Finance Office of Trade & Services United States Securities and Exchange Commission 100 F Street NE Washington, DC 20549 Attn: Robert Shapiro Abe Friedman Re: PetIQ, Inc. Form 10-K for Fiscal Year Ended December 31, 2021 Filed March 1, 2021 Form 8-K Furnished May 4, 2022 File No. 001-38163 Dear Messrs. Shapiro and Friedman,

September 26, 2022 SC 13G

PETQ / PetIQ Inc / Applied Fundamental Research, LLC - SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* PetIQ, Inc (Name of Issuer) Class A Common Stock, $0.001 par value (Title of Class of Securities) 71639T106 (CUSIP Number) September 14, 2022 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant

September 26, 2022 EX-99.1 CHARTER

EX-99.1 CHARTER

EX-99.1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the Class A Common Stock of PetIQ, Inc. and further agree that this Agreement be included as an exhibit to such filing. Each party to t

September 23, 2022 CORRESP

* * *

VIA EDGAR September 23, 2022 Division of Corporation Finance Office of Trade & Services United States Securities and Exchange Commission 100 F Street NE Washington, DC 20549 Attn: Robert Shapiro Abe Friedman Re: PetIQ, Inc.

September 6, 2022 EX-99.1

PetIQ, Inc. Announces $30 Million Stock Repurchase Program

Exhibit 99.1 PetIQ, Inc. Announces $30 Million Stock Repurchase Program EAGLE, Idaho ? September 6, 2022 (GLOBE NEWSWIRE) - PetIQ, Inc. (?PetIQ? or the ?Company?) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced that as part of the Company?s long-term strategy to maximize stockholder value, its Board of Directors has authorized a stock repurchase program, which will e

September 6, 2022 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 6, 2022 PETIQ, INC. (Exact name of registrant as specified in its charter) Delaware 001-38163 35-2554312 (State or other jurisdiction of incorporation) (Commission File Numb

August 22, 2022 CORRESP

August 22, 2022

August 22, 2022 VIA EDGAR Robert Shapiro Abe Friedman Division of Corporation Finance Office of Energy & Transportation United States Securities and Exchange Commission 100 F Street, NE Washington, D.

August 9, 2022 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 9, 2022 PETIQ, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-38163 (Commission File Number) 35-2554312

August 9, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38163 PetIQ,

August 9, 2022 EX-99.1

PetIQ, Inc. Reports Second Quarter 2022 Financial Results Second Quarter 2022 Net Income Increased 16.0% to $4.7 Million Reports Adjusted EBITDA of Approximately $28 Million Provides Third Quarter 2022 Guidance and Updates 2022 Annual Outlook

PetIQ, Inc. Reports Second Quarter 2022 Financial Results Second Quarter 2022 Net Income Increased 16.0% to $4.7 Million Reports Adjusted EBITDA of Approximately $28 Million Provides Third Quarter 2022 Guidance and Updates 2022 Annual Outlook EAGLE, Idaho ? August 9, 2022 (GLOBE NEWSWIRE) - PetIQ, Inc. (?PetIQ? or the ?Company?) (Nasdaq: PETQ), a leading pet medication and wellness company, today

August 2, 2022 CORRESP

August 2, 2022

August 2, 2022 VIA EDGAR Robert Shapiro Abe Friedman Division of Corporation Finance Office of Energy & Transportation United States Securities and Exchange Commission 100 F Street, NE Washington, D.

July 18, 2022 CORRESP

PetIQ, Inc. 230 East Riverside Drive Eagle, ID 83616 July 18, 2022

PetIQ, Inc. 230 East Riverside Drive Eagle, ID 83616 July 18, 2022 VIA EDGAR Robert Shapiro Abe Friedman Division of Corporation Finance Office of Energy & Transportation United States Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549 Re: PetIQ, Inc. Form 10-K for Fiscal Year Ended December 31, 2021 Filed March 1, 2022 Form 8-K Filed May 4, 2022 File No. 001-38163 Dear Mr.

June 24, 2022 EX-FILING FEES

Filing Fee Table.

EX-FILING FEES 4 tm2219212d1ex-filingfees.htm EX-FILING FEES Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) PetIQ, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule (1) Amount Registered (2) Proposed Maximum Offering Price Per Unit (3) Maximum Aggregate Offering Price Fee Rate

June 24, 2022 S-8

As filed with the Securities and Exchange Commission on June 24, 2022.

As filed with the Securities and Exchange Commission on June 24, 2022. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 PETIQ, INC. (Exact name of registrant as specified in its charter) Delaware 35-2554312 (State or Other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Ide

June 23, 2022 EX-3.1

Second Amended and Restated Certificate of Incorporation of PetIQ, Inc.

? Exhibit 3.1 ? TABLE OF CONTENTS ? ? ? ? Article?I Name 1 Article?II Registered Office 1 Article?III Purposes 1 Article?IV Capital Stock 1 1. Authorized Stock 1 2. Common Stock 2 3. Preferred Stock 5 Article?V Bylaws 7 Article?VI Indemnification of Directors 7 1. Limitation of Liability 7 2. Indemnification 8 Article?VII Directors 8 1. Board of Directors 8 2. Number, Term and Classes of Directors

June 23, 2022 8-K

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 23, 2022 (June 22, 2022) PETIQ, INC. (Exact name of registrant as specified in its charter) Delaware 001-38163 35-2554312 (State or other jurisdiction of incorporation) (Commissi

June 23, 2022 EX-3.2

Amended and Restated Bylaws of PetIQ, Inc.

Exhibit 3.2 ? TABLE OF CONTENTS ARTICLE?1 Stockholders 1 1.1 Place of Meetings 1 1.2 Annual Meetings 1 1.3 Special Meetings 1 1.4 Notice of Meetings 1 1.5 Adjournments 1 1.6 Quorum 2 1.7 Organization 2 1.8 Voting; Proxies 3 1.9 Fixing Date for Determination of Stockholders of Record 3 1.10 List of Stockholders Entitled to Vote 4 1.11 Notice of Stockholder Business; Nominations 4 ARTICLE?2 Board of

May 27, 2022 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin

May 19, 2022 EX-99.1

PetIQ, Inc. Announces Executive Leadership Team Changes

Exhibit 99.1 PetIQ, Inc. Announces Executive Leadership Team Changes May 4, 2022 Susan Sholtis, President to Leave the Company, Michael Smith, Executive Vice President Products, to Become President and Chief Operating Officer EAGLE, Idaho, May 04, 2022 (GLOBE NEWSWIRE) - PetIQ, Inc. (?PetIQ? or the ?Company?) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced today that

May 19, 2022 EX-10.1

Transition Support Agreement and General Release, between PetIQ, Inc., and Susan Sholtis.

Exhibit 10.1 TRANSITION SUPPORT AGREEMENT AND GENERAL RELEASE THIS TRANSITION SUPPORT AGREEMENT AND GENERAL RELEASE (the ?Agreement and General Release?) is made and entered into on May 6, 2022 by and among Susan Sholtis (?Executive?) and PetIQ, LLC, an Idaho limited liability company (?Employer?). Executive?s last day of employment will be May 27, 2022 (the ?Retirement Date?). WHEREAS, Executive

May 19, 2022 8-K/A

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 19, 2022 (May 9, 2022) PETIQ, INC. (Exact name of registrant as specified in its charter) Delaware 001-38163 35-2554312 (State or other jurisdiction of incorporation) (Commissio

May 11, 2022 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 9, 2022 PETIQ, INC. (Exact name of registrant as specified in its charter) Delaware 001-38163 35-2554312 (State or other jurisdiction of incorporation) (Commission File Number) (I

May 9, 2022 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 4, 2022 PETIQ, INC. (Exact name of registrant as specified in its charter) Delaware 001-38163 35-2554312 (State or other jurisdiction of incorporation) (Commission File Number) (I

May 9, 2022 EX-99.1

Susan Sholtis, President to Leave the Company, Michael Smith, Executive Vice President Products, to Become President and Chief Operating Officer

Exhibit 99.1 PetIQ, Inc. Announces Executive Leadership Team Changes May 4, 2022 Susan Sholtis, President to Leave the Company, Michael Smith, Executive Vice President Products, to Become President and Chief Operating Officer EAGLE, Idaho, May 04, 2022 (GLOBE NEWSWIRE) - PetIQ, Inc. (?PetIQ? or the ?Company?) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced today that

May 9, 2022 EX-10.1

Form of Transition Support Agreement and General Release, between PetIQ, Inc., and Susan Sholtis.

Exhibit 10.1 TRANSITION SUPPORT AGREEMENT AND GENERAL RELEASE THIS TRANSITION SUPPORT AGREEMENT AND GENERAL RELEASE (the ?Agreement and General Release?) is made and entered into on by and among Susan Sholtis (?Executive?) and PetIQ, LLC, an Idaho limited liability company (?Employer?). Executive?s last day of employment will be May 27, 2022 (the ?Retirement Date?). WHEREAS, Executive has been emp

May 5, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

May 4, 2022 EX-99.1

PetIQ, Inc. Reports Record First Quarter 2022 Financial Results Reports First Quarter Net Sales of $275.7 Million Company Provides Second Quarter 2022 Guidance and Reiterates Full Year 2022 Outlook

? ? PetIQ, Inc. Reports Record First Quarter 2022 Financial Results Reports First Quarter Net Sales of $275.7 Million Company Provides Second Quarter 2022 Guidance and Reiterates Full Year 2022 Outlook EAGLE, Idaho ? May 4, 2022 (GLOBE NEWSWIRE) - PetIQ, Inc. (?PetIQ? or the ?Company?) (Nasdaq: PETQ), a leading pet medication and wellness company, today reported financial results for the first qua

May 4, 2022 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ? FORM 8-K ? CURRENT REPORT ? Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 ? Date of Report (Date of earliest event reported): May 4, 2022 ? PETIQ, INC. (Exact name of registrant as specified in its charter) ? ? ? ? ? ? ? ? ? ? ? Delaware (State or other jurisdiction of incorporation) ? 001-38163

May 2, 2022 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ? FORM 8-K ? CURRENT REPORT ? Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 ? Date of Report (Date of earliest event reported): April 27, 2022 ? PETIQ, INC. (Exact name of registrant as specified in its charter) ? ? ? ? ? ? ? ? ? ? ? Delaware (State or other jurisdiction of incorporation) ? 001-381

April 29, 2022 DEF 14A

PetIQ, Inc. Amended and Restated 2017 Omnibus Incentive Plan (incorporated by reference to Appendix B to the Registrant’s Definitive Proxy Statement on Schedule 14A, filed with the SEC on April 29, 2022).

TABLE OF CONTENTS ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

April 29, 2022 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Defin

April 15, 2022 PRE 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.           )

TABLE OF CONTENTS ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

March 1, 2022 EX-21.1

List of Subsidiaries of PetIQ Inc.

Exhibit 21.1 ? ? ? ? ? ? ? ? ? ? ? List of Subsidiaries of PetIQ Inc. Name of Subsidiary ? State or Country of Incorporation or Organization ECP IV TS Investor Co. ? Delaware PetIQ Holdings, LLC ? Delaware PetIQ, LLC ? Idaho PetIQ, LLC ? Florida TruRX, LLC ? Idaho Tru Prodigy, LLC ? Texas M&C USA, LLC ? Delaware Mark and Chappell Limited ? United Kingdom Mark and Chappell (Ireland) Limited ? Irela

March 1, 2022 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 1, 2022 PETIQ, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-38163 (Commission File Number) 35-2554312

March 1, 2022 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

Table of Contents ? ? ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

March 1, 2022 EX-99.1

PetIQ, Inc. Reports Record Fourth Quarter and Full Year 2021 Financial Results Reports Fourth Quarter Net Sales of $196.6 Million and Full Year Net Sales of $932.5 Million Company Provides First Quarter 2022 and Full Year 2022 Outlook

? ? PetIQ, Inc. Reports Record Fourth Quarter and Full Year 2021 Financial Results Reports Fourth Quarter Net Sales of $196.6 Million and Full Year Net Sales of $932.5 Million Company Provides First Quarter 2022 and Full Year 2022 Outlook EAGLE, Idaho ? March 1, 2022 (GLOBE NEWSWIRE) - PetIQ, Inc. (?PetIQ? or the ?Company?) (Nasdaq: PETQ), a leading pet medication and wellness company, today repor

February 14, 2022 EX-99.1

JOINT FILING AGREEMENT

Exhibit 1 JOINT FILING AGREEMENT Pursuant to Rule 13d-1(k)(1)(iii), we the undersigned agree that the Schedule 13G, to which this Joint Filing Agreement is attached as Exhibit 1, is filed on behalf of each of us.

February 14, 2022 SC 13G

PETQ / PetIQ Inc / MACQUARIE GROUP LTD - SC 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 0)* PetIQ Inc. (Name of Issuer) Common Shares (Title of Class of Securities) 71639T106 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is

February 14, 2022 SC 13G/A

PETQ / PetIQ Inc / Ecp Helios Partners Iv, L.p. - SC 13G/A Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* PetIQ, Inc. (Name of Issuer) Class A Common Stock (Title of Class of Securities) 71639T106 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sch

February 11, 2022 SC 13G/A

PETQ / PetIQ Inc / Clarke James Nathan - SC 13G/A Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4)* PetIQ, Inc. (Name of Issuer) Class A Common Stock, $0.001 par value per share (Title of Class of Securities) 71639T106 (CUSIP Number) 230 E. Riverside Dr., Eagle, ID 83616 208-939-8900 (Name, Address and Telephone Number of Person Authorized to Receive N

February 11, 2022 SC 13G/A

PETQ / PetIQ Inc / GENEVA CAPITAL MANAGEMENT LLC - AMENDMENT NO. 1 TO SCHEDULE 13G Passive Investment

SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1) PetIQ, Inc. (Name of Issuer) Class A Common Stock (Title of Class of Securities) 71639T106 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to wh

January 6, 2022 EX-99.1

PetIQ, Inc. Announces Appointment of Financial Executive Kenneth Walker to the Board of Directors

Exhibit 99.1 PetIQ, Inc. Announces Appointment of Financial Executive Kenneth Walker to the Board of Directors EAGLE, Idaho ? January 6, 2022 (GLOBE NEWSWIRE) - PetIQ, Inc. (?PetIQ? or the ?Company?) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced the appointment of Kenneth Walker as an independent director on its Board of Directors, effective January 3, 2022. He wil

January 6, 2022 8-K

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 3, 2022 PETIQ, INC. (Exact name of registrant as specified in its charter) Delaware 001-38163 35-2554312 (State or other jurisdiction of incorporation) (Commission File Number

January 5, 2022 8-K

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 6, 2021 PETIQ, INC. (Exact name of registrant as specified in its charter) Delaware 001-38163 35-2554312 (State or other jurisdiction of incorporation) (Commission File Numbe

January 5, 2022 EX-99.1

PetIQ, Inc. Appoints New CFO Zvi Glasman, Proven Financial and Strategic Executive, Joins Company as CFO

Exhibit 99.1 PetIQ, Inc. Appoints New CFO Zvi Glasman, Proven Financial and Strategic Executive, Joins Company as CFO EAGLE, Idaho ? January 5, 2022 (GLOBE NEWSWIRE) - PetIQ, Inc. (?PetIQ? or the ?Company?) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced the appointment of Zvi Glasman, as its Chief Financial Officer (?CFO?), effective January 3, 2022. Glasman has 20

January 5, 2022 EX-10.1

Employment and Non-Competition Agreement, dated December 6, 2021, between PetIQ, LLC and Zvi Glasman

Exhibit 10.1 EXECUTION VERSION EMPLOYMENT AND NON-COMPETITION AGREEMENT EMPLOYMENT AND NON-COMPETITION AGREEMENT (this ?Agreement?) dated as of December 6, 2021, between PetIQ, LLC, an Idaho limited liability company (the ?Company?), and Zvi Glasman (the ?Employee?). WHEREAS, the Company and the Employee desire to enter into this Agreement in order to set forth the respective rights and obligation

November 4, 2021 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

November 3, 2021 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ? FORM 8-K ? CURRENT REPORT ? Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 ? Date of Report (Date of earliest event reported): November 3, 2021 ? PETIQ, INC. (Exact name of registrant as specified in its charter) ? ? ? ? ? ? ? ? ? ? ? Delaware (State or other jurisdiction of incorporation) ? 001-3

November 3, 2021 EX-99.1

PetIQ, Inc. Reports Record Third Quarter 2021 Financial Results Reports Record Third Quarter Net Sales of $210.5 Million, an Increase of 29.9% Year-Over-Year

PetIQ, Inc. Reports Record Third Quarter 2021 Financial Results Reports Record Third Quarter Net Sales of $210.5 Million, an Increase of 29.9% Year-Over-Year EAGLE, Idaho ? November 3, 2021 (GLOBE NEWSWIRE) - PetIQ, Inc. (?PetIQ? or the ?Company?) (Nasdaq: PETQ), a leading pet medication and wellness company, today reported financial results for the third quarter and nine months ended September 30

September 10, 2021 SC 13G/A

PETQ / PetIQ Inc / ALGER ASSOCIATES INC - PETIQ INC. Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* PetIQ, Inc. (Name of Issuer) Class A Common Stock (Title of Class of Securities) 71639T106 (CUSIP Number) August 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sched

August 12, 2021 8-K/A

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ? FORM 8-K/A ? CURRENT REPORT ? Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 ? Date of Report (Date of earliest event reported):August 3, 2021 ? PETIQ, INC. (Exact name of registrant as specified in its charter) ? ? ? ? ? ? ? ? ? ? ? Delaware (State or other jurisdiction of incorporation) ? 001-38

August 12, 2021 EX-99.1

John Newland to Retire After More than Seven Years as CFO Company initiates Search for Successor

John Newland to Retire After More than Seven Years as CFO Company initiates Search for Successor EAGLE, Idaho, Aug.

August 12, 2021 EX-10.1

Transition Support Agreement and General Release, dated as of August 3, between PetIQ, Inc., and John Newland.

Exhibit 10.1 ? TRANSITION SUPPORT AGREEMENT AND GENERAL RELEASE ? THIS TRANSITION SUPPORT AGREEMENT AND GENERAL RELEASE (the ?Agreement and General Release?) is made and entered into on August 3, 2021 by and among John Newland (?Executive?) and PetIQ, LLC, an Idaho limited liability company (?Employer?). Executive?s last day of employment will be the later of (i) the date on which the 2021 Form 10

August 10, 2021 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ? FORM 8-K ? CURRENT REPORT ? Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 ? Date of Report (Date of earliest event reported):August 3, 2021 ? PETIQ, INC. (Exact name of registrant as specified in its charter) ? ? ? ? ? ? ? ? ? ? ? Delaware (State or other jurisdiction of incorporation) ? 001-3816

August 10, 2021 EX-99.1

John Newland to Retire After More than Seven Years as CFO Company initiates Search for Successor

John Newland to Retire After More than Seven Years as CFO Company initiates Search for Successor EAGLE, Idaho, Aug.

August 10, 2021 EX-10.1

Transition Support Agreement and General Release, dated as of August 3, between PetIQ, Inc., and John Newland.

Exhibit 10.1 ? TRANSITION SUPPORT AGREEMENT AND GENERAL RELEASE ? THIS TRANSITION SUPPORT AGREEMENT AND GENERAL RELEASE (the ?Agreement and General Release?) is made and entered into on August 3, 2021 by and among John Newland (?Executive?) and PetIQ, LLC, an Idaho limited liability company (?Employer?). Executive?s last day of employment will be the later of (i) the date on which the 2021 Form 10

August 5, 2021 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

August 4, 2021 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ? FORM 8-K ? CURRENT REPORT ? Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 ? Date of Report (Date of earliest event reported): July 29, 2021 ? PETIQ, INC. (Exact name of registrant as specified in its charter) ? ? ? ? ? ? ? ? ? ? ? Delaware (State or other jurisdiction of incorporation) ? 001-3816

August 4, 2021 EX-99.1

PetIQ, Inc. Reports Record Second Quarter 2021 Financial Results

PetIQ, Inc. Reports Record Second Quarter 2021 Financial Results EAGLE, Idaho ? August 4, 2021 (GLOBE NEWSWIRE) - PetIQ, Inc. (?PetIQ? or the ?Company?) (Nasdaq: PETQ), a leading pet medication and wellness company, today reported financial results for the second quarter and six months ended June 30, 2021. Cord Christensen, PetIQ?s Chairman & CEO commented, ?We are pleased with our ability to repo

August 4, 2021 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ? FORM 8-K ? CURRENT REPORT ? Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 ? Date of Report (Date of earliest event reported): July 29, 2021 ? PETIQ, INC. (Exact name of registrant as specified in its charter) ? ? ? ? ? ? ? ? ? ? ? Delaware (State or other jurisdiction of incorporation) ? 001-3816

July 6, 2021 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Submission of Matters to a Vote of Security Holders

? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ? FORM 8-K ? CURRENT REPORT ? Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 ? Date of Report (Date of earliest event reported): June 29, 2021 ? PETIQ, INC. (Exact name of registrant as specified in its charter) ? ? ? ? ? ? ? ? ? ? ? Delaware (State or other jurisdiction of incorporation) ? 001-3816

June 25, 2021 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin

May 7, 2021 10-Q

Quarterly Report - 10-Q

Table of Contents ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

May 5, 2021 EX-99.1

PetIQ, Inc. Reports Record First Quarter 2021 Financial Results First Quarter 2021 Net Sales Increase 36.2% Year-Over-Year to $254.3 Million

PetIQ, Inc. Reports Record First Quarter 2021 Financial Results First Quarter 2021 Net Sales Increase 36.2% Year-Over-Year to $254.3 Million EAGLE, Idaho - May 5, 2021 (GLOBE NEWSWIRE) - PetIQ, Inc. (?PetIQ? or the ?Company?) (Nasdaq: PETQ), a leading pet medication and wellness company, today reported financial results for the three months ended March 31, 2021. Cord Christensen, PetIQ?s Chairman

May 5, 2021 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ? FORM 8-K ? CURRENT REPORT ? Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 ? Date of Report (Date of earliest event reported): May 5, 2021 ? PETIQ, INC. (Exact name of registrant as specified in its charter) ? ? ? ? ? ? ? ? ? ? ? Delaware (State or other jurisdiction of incorporation) ? 001-38163

April 30, 2021 DEF 14A

- DEF 14A

TABLE OF CONTENTS ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

April 30, 2021 DEFA14A

- DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin

April 19, 2021 8-K

Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits, Other Events

? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ? FORM 8-K ? CURRENT REPORT ? Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 ? Date of Report (Date of earliest event reported): April 13, 2021 ? PETIQ, INC. (Exact name of registrant as specified in its charter) ? ? ? ? ? ? ? ? ? ? ? Delaware (State or other jurisdiction of incorporation) ? 001-381

April 19, 2021 EX-99.1

PetIQ, Inc. Enters Into a New $425 Million Credit Facility Increases Borrowing Capacity by Approximately $109 Million Refinancing Significantly Reduces Interest Rate and Extends Maturity with Increased Operational Flexibility

PetIQ, Inc. Enters Into a New $425 Million Credit Facility Increases Borrowing Capacity by Approximately $109 Million Refinancing Significantly Reduces Interest Rate and Extends Maturity with Increased Operational Flexibility EAGLE, ID ? April 19, 2021 (Globe Newswire) - PetIQ, Inc. (?PetIQ? or the ?Company?) (Nasdaq: PETQ) today announced it has entered into a new $300 million term loan (?Term Lo

April 19, 2021 EX-10.1

ABL Credit and Guaranty Agreement, dated as of April 13, 2021, among PetIQ Holdings, LLC, PetIQ, the guarantor subsidiaries party thereto, the lenders party thereto and Keybank National Association, as administrative and collateral agent

Published Transaction CUSIP Number: 71639UAC7 Revolving Facility CUSIP Number: 71639UAD5 ? ? ABL CREDIT AND GUARANTY AGREEMENT dated as of April 13, 2021, among PETIQ HOLDINGS, LLC, PETIQ, LLC, CERTAIN SUBSIDIARIES OF PETIQ HOLDINGS, LLC, as Guarantor Subsidiaries, THE LENDERS PARTY HERETO and KEYBANK NATIONAL ASSOCIATION, as Administrative Agent and Collateral Agent KEYBANC CAPITAL MARKETS INC.

April 19, 2021 EX-10.2

Term Credit and Guaranty Agreement, dated as of April 13, 2021, among PetIQ Holdings, LLC, PetIQ, LLC, the guarantor subsidiaries party thereto, the lenders party thereto and Jefferies Finance LLC, as administrative and collateral agent

TERM CREDIT AND GUARANTY AGREEMENT dated as of April 13, 2021, among PETIQ HOLDINGS, LLC, PETIQ, LLC, CERTAIN SUBSIDIARIES OF PETIQ HOLDINGS, LLC, as Guarantor Subsidiaries, THE LENDERS PARTY HERETO and JEFFERIES FINANCE LLC, as Administrative Agent and Collateral Agent JEFFERIES FINANCE LLC and KEYBANC CAPITAL MARKETS INC.

March 10, 2021 SC 13G/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Amendment No. 2* PetIQ, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) (CUSIP Number) February 28, 2021

PetIQ, Inc. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Amendment No. 2* PetIQ, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 71639T106 (CUSIP Number) February 28, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this S

March 10, 2021 EX-99.3

POWER OF ATTORNEY

Power of Attorney EXHIBIT 3 POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS, THAT: The undersigned, Waddell & Reed Financial, Inc.

March 10, 2021 EX-99.2

EXHIBIT 2

Identification and Classification of the Subsidiary Which Acquired the Security EXHIBIT 2 Ivy Investment Management Company - Tax ID No. 03-0481447 Investment Advisor registered under Section 203 of the Investment Advisors Act of 1940

March 10, 2021 EX-99.1

JOINT FILING AGREEMENT

Joint Filing Agreement EXHIBIT 1 JOINT FILING AGREEMENT Waddell & Reed Financial, Inc.

March 1, 2021 EX-21.1

List of Subsidiaries of PetIQ Inc.

Exhibit 21.1 ? ? ? ? ? ? ? ? ? ? ? List of Subsidiaries of PetIQ Inc. Name of Subsidiary ? State or Country of Incorporation or Organization ECP IV TS Investor Co. ? Delaware PetIQ Holdings, LLC ? Delaware PetIQ, LLC ? Idaho PetIQ, LLC ? Florida TruRX, LLC ? Idaho Tru Prodigy, LLC ? Texas M&C USA, LLC ? Delaware Mark and Chappell Limited ? United Kingdom Mark and Chappell (Ireland) Limited ? Irela

March 1, 2021 10-K

Annual Report - 10-K

Table of Contents ? ? ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

February 25, 2021 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ? FORM 8-K ? CURRENT REPORT ? Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 ? Date of Report (Date of earliest event reported): February 25, 2021 ? PETIQ, INC. (Exact name of registrant as specified in its charter) ? ? ? ? ? ? ? ? ? ? ? Delaware (State or other jurisdiction of incorporation) ? 001-

February 25, 2021 EX-99.1

PetIQ, Inc. Reports Fourth Quarter and Full Year 2020 Financial Results Reports Fourth Quarter 2020 Net Sales of $164.2 Million; Full Year 2020 Net Sales of $780.1 Million

PetIQ, Inc. Reports Fourth Quarter and Full Year 2020 Financial Results Reports Fourth Quarter 2020 Net Sales of $164.2 Million; Full Year 2020 Net Sales of $780.1 Million EAGLE, Idaho - February 25, 2021 (GLOBE NEWSWIRE) - PetIQ, Inc. (?PetIQ? or the ?Company?) (Nasdaq: PETQ), a leading pet medication and wellness company, today reported financial results for the three and twelve months ended Dec

February 24, 2021 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 24, 2021 PETIQ, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-38163 (Commission File Number) 35-2554

February 24, 2021 EX-3.1

Amended and Restated Bylaws of PetIQ, Inc.

AMENDED AND RESTATED BYLAWS ? OF ? PETIQ, INC. ? Adopted February 19, 2021 ? Article 1 ? Stockholders ? 1.1 Place of Meetings. Meetings of stockholders of PetIQ, Inc., a Delaware corporation (the ?Corporation?), shall be held at the place, either within or without the State of Delaware, as may be designated by the Board of Directors of the Corporation (the ?Board of Directors?) from time to time.

February 24, 2021 EX-99.1

PetIQ, Inc. Appoints Two New Independent Directors with Extensive Consumer-Packaged Goods and Marketing Experience

EX-99.1 3 petq-20210224xex99d1.htm EX-99.1 PetIQ, Inc. Appoints Two New Independent Directors with Extensive Consumer-Packaged Goods and Marketing Experience EAGLE, Idaho - February 24, 2021 (GLOBE NEWSWIRE) - PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced the appointments of Sheryl Oloughlin and Kim Lefko as independent direct

February 16, 2021 SC 13G/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* PetIQ, Inc. (Name of Issuer) Class A Common Stock, $0.001 par value per share (Title of Class of Securit

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* PetIQ, Inc. (Name of Issuer) Class A Common Stock, $0.001 par value per share (Title of Class of Securities) 71639T106 (CUSIP Number) 923 S. Bridgeway Pl, Eagle, ID 83616 208-939-8900 (Name, Address and Telephone Number of Person Authorized to Receive No

February 16, 2021 SC 13G

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* PetIQ Inc. (Name of Issuer) Common Stock (Title of Class of Securities) (CUSIP Number) December 31, 2020

PetIQ Inc. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* PetIQ Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 71639T106 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sc

February 12, 2021 SC 13G

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. __) PetIQ, Inc. (Name of Issuer) Class A Common Stock (Title of Class of Securities 71639T106 CUSIP Number D

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. ) PetIQ, Inc. (Name of Issuer) Class A Common Stock (Title of Class of Securities 71639T106 CUSIP Number December 31, 2020 (Date of Event Which Requires Filing of this Statement Check the appropriate box to designate the rule pursuant to which this Schedule

February 12, 2021 EX-99.1

JOINT FILING AGREEMENT

EX-99.1 2 d122146dex991.htm JOINT FILING AGREEMENT EXHIBIT 1 JOINT FILING AGREEMENT Waddell & Reed Financial, Inc., and Ivy Investment Management Company (the “Filing Persons”), hereby agree to file jointly a Schedule 13G and any amendments thereto relating to the aggregate ownership by each of the Filing Persons of any voting equity security of a class which is registered pursuant to Section 12 o

February 12, 2021 EX-99.3

POWER OF ATTORNEY

Power of Attorney EXHIBIT 3 POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS, THAT: The undersigned, Waddell & Reed Financial, Inc.

February 12, 2021 EX-99.2

EXHIBIT 2

EX-99.2 3 d122146dex992.htm IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY EXHIBIT 2 Ivy Investment Management Company - Tax ID No. 03-0481447 Investment Advisor registered under Section 203 of the Investment Advisors Act of 1940

February 12, 2021 SC 13G/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Amendment No. 1* PetIQ, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) (CUSIP Number) December 31, 2020

PetIQ Inc. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Amendment No. 1* PetIQ, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 71639T106 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sc

December 23, 2020 8-K

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events - 8-K

Lin UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 17, 2020 PETIQ, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-38163 (Commission File Number) 35-

November 6, 2020 10-Q

Quarterly Report - 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38163 P

November 5, 2020 EX-99.1

PetIQ, Inc. Reports Third Quarter 2020 Financial Results

EX-99.1 2 petq-20201105xex99d1.htm EX-99.1 PetIQ, Inc. Reports Third Quarter 2020 Financial Results EAGLE, Idaho, November 5, 2020 (GLOBE NEWSWIRE) - PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today reported financial results for the three and nine months ended September 30, 2020. “We are incredibly proud of our team’s collaboration, resil

November 5, 2020 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 5, 2020 PETIQ, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-38163 (Commission File Number) 35-25543

August 31, 2020 EX-99

JOINT FILING AGREEMENT

Exhibit 99.1 JOINT FILING AGREEMENT This Joint Filing Agreement, dated as of August 31, 2020 is by and among Yiheng Capital Partners, L.P., Yiheng Capital Management, L.P., Yiheng Capital LLC, and Yuanshan Guo (collectively, the "Filers"). Each of the Filers may be required to file with the United States Securities and Exchange Commission a statement on Schedule 13G and/or 13D with respect to Comm

August 31, 2020 SC 13G

PETQ / PetIQ, Inc. / Yiheng Capital Management, L.P. - SC 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.)* PetIQ, Inc. (Name of Issuer) Class A Common Stock, $0.001 par value (Title of Class of Securities) 71639T106** (CUSIP Number) Yiheng Capital Management, L.P. 101 California Street, Suite 2880 San Francisco, CA 94111 415-582-6360 (Name, Address and Telephon

August 10, 2020 EX-10.2

Third Amendment to Term Loan Credit Agreement, dated July 9, 2020, by and among PetIQ, LLC, the guarantors party thereto, Ares Capital Corporation, as a lender and as the administrative agent, and the other lenders party thereto

Exhibit 10.2 THIRD AMENDMENT TO TERM LOAN CREDIT AGREEMENT This THIRD AMENDMENT TO TERM LOAN CREDIT AGREEMENT (this “Amendment”) is dated as of July 9, 2020 and is entered into by and among PETIQ, LLC, an Idaho limited liability company (the “Borrower”), the Guarantors party hereto, ARES CAPITAL CORPORATION and each other Lender party hereto (consisting of the Required Lenders) and ARES CAPITAL CO

August 10, 2020 EX-2.1

Amended and Restated Asset Purchase Agreement, dated June 21, 2020, by and between Elanco US Inc., PetIQ, LLC and PetIQ, Inc.

Exhibit 2.1 AMENDED AND RESTATED ASSET PURCHASE AGREEMENT by and between ELANCO US, INC., and PETIQ, LLC, and, for purposes of Section 9.16 only, PETIQ, INC. Dated as of June 21, 2020 TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS 1 1.1 Certain Defined Terms 1 1.2 Construction 15 1.3 Consistency with Final Consent Orders 16 1.4 Disclosure Schedules 16 ARTICLE 2 SALE AND PURCHASE OF ASSETS; LIABILITI

August 10, 2020 10-Q

Quarterly Report - 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38163 PetIQ,

August 10, 2020 EX-10.5

Fifth Amendment to Amended and Restated Revolving Credit Agreement, dated July 9, 2020, by and among PetIQ, LLC, East West Bank, as a lender and as the administrative agent, the lenders party thereto and the other credit parties party thereto

Exhibit 10.5 FIFTH AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT THIS FIFTH AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT (this “Amendment”), dated as of July 9, 2020, is entered into by and among PETIQ, LLC, an Idaho limited liability company (“PetIQ”), the other Credit Parties signatory hereto (collectively with PetIQ, the “Borrowers”), the LENDERS signatory hereto, and EAST WEST BANK,

August 6, 2020 EX-99.1

PetIQ, Inc. Reports Record Second Quarter 2020 Financial Results Consolidated Net Sales Increased 21.0% Year-Over-Year to $267.0 Million, Despite Services Segment Closures Related to COVID-19 Outlines Services Segment Reopening Plan Provides Third Qu

PetIQ, Inc. Reports Record Second Quarter 2020 Financial Results Consolidated Net Sales Increased 21.0% Year-Over-Year to $267.0 Million, Despite Services Segment Closures Related to COVID-19 Outlines Services Segment Reopening Plan Provides Third Quarter Net Sales and Adjusted EBITDA Guidance EAGLE, Idaho – August 6, 2020 – PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medi

August 6, 2020 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 6, 2020 PETIQ, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-38163 (Commission File Number) 35-2554312

August 3, 2020 EX-99.1

PetIQ, Inc. Closes Acquisition of Capstar® Portfolio of Products Accretive, Strategic Transaction Adds High-margin Sales and Enhances Product Manufacturing

Exhibit 99.1 PetIQ, Inc. Closes Acquisition of Capstar® Portfolio of Products Accretive, Strategic Transaction Adds High-margin Sales and Enhances Product Manufacturing EAGLE, Idaho – August 3, 2020 – PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company today announced the closing of the acquisition of the Capstar® portfolio of products, effective Ju

August 3, 2020 8-K

Regulation FD Disclosure, Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets

Lin UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 28, 2020 PETIQ, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-38163 (Commission File Number) 35-2554

August 3, 2020 EX-10.1

Fourth Amendment to Term Loan Credit Agreement and First Amendment to Security Agreement, dated July 28, 2020, by and among PetIQ, LLC, the guarantors party thereto, Ares Capital Corporation, as a lender and as the administrative agent, and the other lenders party thereto

EX-10.1 2 tmb-20200728xex10d1.htm EX-10.1 Exhibit 10.1 FOURTH AMENDMENT TO TERM LOAN CREDIT AGREEMENT AND FIRST AMENDMENT TO SECURITY AGREEMENT This FOURTH AMENDMENT TO TERM LOAN CREDIT AGREEMENT AND FIRST AMENDMENT TO SECURITY AGREEMENT (this “Amendment”) is dated as of July 28, 2020 and is entered into by and among PETIQ, LLC, an Idaho limited liability company (the “Borrower”), the Guarantors p

August 3, 2020 EX-10.2

Six Amendment to Amended and Restated Credit Agreement, dated July 28, 2020, by and among PetIQ, LLC, and the other credit parties thereto, the lenders party thereto and East West Bank, as administrative agent.

Exhibit 10.2 SIXTH AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT AND FIRST AMENDMENT TO SECURITY AGREEMENT THIS SIXTH AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT AND FIRST AMENDMENT TO SECURITY AGREEMENT (this “Amendment”), dated as of July 28, 2020, is entered into by and among PETIQ, LLC, an Idaho limited liability company (“PetIQ”), the other Credit Parties signatory hereto (collect

June 30, 2020 8-K

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Lin UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 25, 2020 PETIQ, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-38163 (Commission File Number) 35-2554

June 18, 2020 8-K

Submission of Matters to a Vote of Security Holders

Lin UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 18, 2020 PETIQ, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-38163 (Commission File Number) 35-2554

May 20, 2020 EX-10.1

Form of Base Capped Call Transaction Confirmation

Exhibit 10.1 [Dealer] May 14, 2020 To: PetIQ, Inc. 923 S. Bridgeway Place Eagle, Idaho 83616 Attention: General Counsel Re: Base Call Option Transaction The purpose of this letter agreement (this “Confirmation”) is to confirm the terms and conditions of the call option transaction entered into between [] (“Dealer”) and PetIQ, Inc. (“Counterparty”) as of the Trade Date specified below (the “Transac

May 20, 2020 EX-10.2

Form of Additional Capped Call Transaction Confirmation

EX-10.2 4 tm2019728d2ex10-2.htm EXHIBIT 10.2 Exhibit 10.2 [Dealer] May 18, 2020 To: PetIQ, Inc. 923 S. Bridgeway Place Eagle, Idaho 83616 Attention: General Counsel Re: Additional Call Option Transaction The purpose of this letter agreement (this “Confirmation”) is to confirm the terms and conditions of the call option transaction entered into between (“Dealer”) and PetIQ, Inc. (“Counterparty”) as

May 20, 2020 EX-99.1

PetIQ, Inc. Prices $125 Million Convertible Senior Notes Offering Proceeds to be Used to Fund Capstar Acquisition Capped Call to Increase Effective Conversion Price to $41.51 (75% Effective Conversion Premium)

EX-99.1 5 tm2019728d2ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 PetIQ, Inc. Prices $125 Million Convertible Senior Notes Offering Proceeds to be Used to Fund Capstar Acquisition Capped Call to Increase Effective Conversion Price to $41.51 (75% Effective Conversion Premium) EAGLE, Idaho, May 14, 2020 (GLOBE NEWSWIRE) - PetIQ, Inc. (“PetIQ”) (NasdaqGS: PETQ) today announced the pricing of its offering of

May 20, 2020 8-K

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 14, 2020 PETIQ, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-38163 (Commission File Number) 35-2554312 (

May 20, 2020 EX-4.1

Indenture, dated May 14, 2020, among PetIQ, Inc. and Wells Fargo, National Association, as trustee

EX-4.1 2 tm2019728d2ex4-1.htm EXHIBIT 4.1 Exhibit 4.1 EXECUTION VERSION PETIQ, INC. and WELLS FARGO BANK, NATIONAL ASSOCIATION as Trustee INDENTURE Dated as of May 19, 2020 4.00% Convertible Senior Notes due 2026 TABLE OF CONTENTS Page Article 1. Definitions; Rules of Construction 1 Section 1.01. Definitions 1 Section 1.02. Other Definitions 13 Section 1.03. Rules of Construction 13 Article 2. The

May 14, 2020 EX-99.1

PetIQ, Inc. Announces Proposed Convertible Senior Notes Offering to Fund Capstar Acquisition

Exhibit 99.1 PetIQ, Inc. Announces Proposed Convertible Senior Notes Offering to Fund Capstar Acquisition EAGLE, Idaho, May 14, 2020 (GLOBE NEWSWIRE) - PetIQ, Inc. (“PetIQ”) (NasdaqGS: PETQ) today announced its intention to offer, subject to market and other conditions, $125,000,000 aggregate principal amount of convertible senior notes due 2026 (the “notes”) in a private offering to qualified ins

May 14, 2020 EX-10.1

Second Amendment to Term Loan Credit Agreement, dated July 9, 2020, by and among PetIQ, LLC, Ares Capital Corporation and the Lenders party thereto

EX-10.1 2 tm2019702d1ex10-1.htm EXHIBIT 10.1 Exhibit 10.1 SECOND AMENDMENT TO TERM LOAN CREDIT AGREEMENT This SECOND AMENDMENT TO TERM LOAN CREDIT AGREEMENT (this “Amendment”) is dated as of May 14, 2020 and is entered into by and among PETIQ, LLC, an Idaho limited liability company (the “Borrower”), the Guarantors party hereto, ARES CAPITAL CORPORATION and each other Lender party hereto (consisti

May 14, 2020 EX-10.2

Fourth Amendment to Amended and Restated Credit Agreement, dated as of May 14, 2020, by and among PetIQ, LLC, the other Credit Parties signatory thereto, the Lenders party thereto, and East West Bank, as administrative agent.

Exhibit 10.2 FOURTH AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT THIS FOURTH AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT (this “Amendment”), dated as of May 14, 2020, is entered into by and among PETIQ, LLC, an Idaho limited liability company (“PetIQ”), the other Credit Parties signatory hereto (collectively with PETIQ, the “Borrowers”), the LENDERS signatory hereto, and EAST WEST BAN

May 14, 2020 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 14, 2020 PETIQ, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-38163 (Commission File Number) 35-2554312 (

May 8, 2020 10-Q

Quarterly Report - 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38163 PetIQ

May 7, 2020 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 7, 2020 PETIQ, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-38163 (Commission File Number) 35-2554312 (I

May 7, 2020 EX-99.1

PetIQ, Inc. Reports Record First Quarter 2020 Financial Results First Quarter 2020 Net Sales Increased 26% Year-Over-Year to $186.8 Million Provides Business Update on COVID-19

PetIQ, Inc. Reports Record First Quarter 2020 Financial Results First Quarter 2020 Net Sales Increased 26% Year-Over-Year to $186.8 Million Provides Business Update on COVID-19 EAGLE, Idaho – May 7, 2020 – PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today reported financial results for the first quarter ended March 31, 2020. “The world chan

April 29, 2020 DEF 14A

- DEF 14A

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.           ) Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted

April 29, 2020 DEFA14A

- DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin

March 20, 2020 8-K

Regulation FD Disclosure, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 20, 2020 PETIQ, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-38163 (Commission File Number) 35-2554312

March 20, 2020 EX-99.1

PetIQ, Inc. Announces Business Update Related to COVID-19

PetIQ, Inc. Announces Business Update Related to COVID-19 EAGLE, Idaho – March 20, 2020 – PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced that out of an abundance of caution for its employees and customers in response to COVID-19 all veterinary community clinics and wellness centers will temporarily close effective Friday, March

March 11, 2020 EX-21.1

List of Subsidiaries of PetIQ Inc.

EX-21.1 4 petq-20191231ex2118cfeb4.htm EX-21.1 Exhibit 21.1 List of Subsidiaries of PetIQ Inc. Name of Subsidiary State or Country of Incorporation or Organization PetIQ Holdings, LLC Delaware PetIQ, LLC Idaho True Science Holdings, LLC Florida TruRX, LLC Idaho Tru Prodigy, LLC Texas M&C USA, LLC Delaware Mark and Chappell Limited United Kingdom Mark and Chappell (Ireland) Limited Ireland Prodex D

March 11, 2020 EX-2.2

Asset Purchase Agreement, dated January 13, 2020, by and between Elanco US Inc., PetIQ, LLC and PetIQ, Inc.

CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.

March 11, 2020 EX-4.4

Description of PetIQ, Inc.’s Securities

Exhibit 4.4 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The following descriptions of the capital stock of PetIQ, Inc. and of certain provisions of Delaware law are subject to and qualified in their entirety by reference to our Amended and Restated Certificate of Incorporation (the “Certificate”) and our Bylaws (the “Bylaws”)

March 11, 2020 10-K

PETQ / PetIQ, Inc. 10-K - Annual Report - 10-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: PetIQ, Inc. (Exact n

March 10, 2020 EX-99.1

PetIQ, Inc. Reports Record Full Year 2019 and Fourth Quarter Financial Results Full Year 2019 Net Sales of $709.4 Million; Fourth Quarter Net Sales of $154.3 Million Provides Full Year 2020 Outlook

PetIQ, Inc. Reports Record Full Year 2019 and Fourth Quarter Financial Results Full Year 2019 Net Sales of $709.4 Million; Fourth Quarter Net Sales of $154.3 Million Provides Full Year 2020 Outlook EAGLE, Idaho – March 10, 2020 – PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today reported financial results for the fourth quarter and full yea

March 10, 2020 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 10, 2020 PETIQ, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-38163 (Commission File Number) 35-2554312

February 14, 2020 SC 13G

PETQ / PetIQ, Inc. / Alger Associates Inc - SC 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* PetIQ Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 71639T106 (CUSIP Number) December 31, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is f

February 14, 2020 SC 13G/A

PETQ / PetIQ, Inc. / TimesSquare Capital Management, LLC - SC 13G/A Passive Investment

SC 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)1 PetIQ, Inc. (Name of Issuer) Common Stock, $.001 par value (Title of Class of Securities) 71639T106 (CUSIP Number) December 31, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this

February 14, 2020 SC 13G/A

PETQ / PetIQ, Inc. / Clarke James Nathan - SCHEDULE 13G/A Passive Investment

SC 13G/A 1 tm207772-1sc13ga.htm SCHEDULE 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* PetIQ, Inc. (Name of Issuer) Class A Common Stock, $0.001 par value per share (Title of Class of Securities) 71639T106 (CUSIP Number) 923 S. Bridgeway Pl, Eagle, ID 83616 208-939-8900 (Name, Address and Tele

February 14, 2020 EX-99.1

JOINT FILING AGREEMENT

Joint Filing Agreement EXHIBIT 1 JOINT FILING AGREEMENT Waddell & Reed Financial, Inc.

February 14, 2020 SC 13G

PETQ / PetIQ, Inc. / WADDELL & REED FINANCIAL INC - PETIQ, INC. Passive Investment

PetIQ, Inc. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 PetIQ, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 71639T106 (CUSIP Number) December 31, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

February 14, 2020 EX-99.2

EXHIBIT 2

Identification and Classification of the Subsidiary Which Acquired the Security EXHIBIT 2 Ivy Investment Management Company - Tax ID No. 03-0481447 Investment Advisor registered under Section 203 of the Investment Advisors Act of 1940

February 14, 2020 EX-99.3

POWER OF ATTORNEY

Power of Attorney EXHIBIT 3 POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS, THAT: The undersigned, Waddell & Reed Financial, Inc.

January 15, 2020 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 13, 2020 PETIQ, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-38163 (Commission File Number) 35-25543

January 15, 2020 EX-99.1

PetIQ, Inc. Enters Into Definitive Agreement to Acquire the Capstar® portfolio of products from Elanco Accretive, Strategic Bolt-on Acquisition Provides High-margin Revenue Opportunity and Further Bolsters Manufacturing

PetIQ, Inc. Enters Into Definitive Agreement to Acquire the Capstar® portfolio of products from Elanco Accretive, Strategic Bolt-on Acquisition Provides High-margin Revenue Opportunity and Further Bolsters Manufacturing EAGLE, Idaho – January 13, 2020 – PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, and Elanco today announced they have execute

November 8, 2019 10-Q

PETQ / PetIQ, Inc. 10-Q - Quarterly Report - 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number:

November 7, 2019 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 7, 2019 PETIQ, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-38163 (Commission File Number) 35-25543

November 7, 2019 EX-99.1

PetIQ, Inc. Reports Record Third Quarter 2019 Financial Results Third Quarter 2019 Net Sales Increased 42% Year-Over-Year to $186 Million Reiterates Full Year 2019 Outlook On Track to Open 80 Planned Wellness Centers in 2019

PetIQ, Inc. Reports Record Third Quarter 2019 Financial Results Third Quarter 2019 Net Sales Increased 42% Year-Over-Year to $186 Million Reiterates Full Year 2019 Outlook On Track to Open 80 Planned Wellness Centers in 2019 EAGLE, Idaho – November 7, 2019 – PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today reported financial results for th

November 4, 2019 CORRESP

PETQ / PetIQ, Inc. CORRESP - -

CORRESP North America Europe Asia 35 W. Wacker Drive Chicago, IL 60601 T +1 312 558 5600 F +1 312 558 5700 November 4, 2019 Suying Li Rufus Decker Division of Corporation Finance Office of Beverages, Apparel and Mining United States Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549 Re: PetIQ, Inc. Form 10-K for Fiscal Year Ended December 31, 2018 Filed March 12, 2019 Form

October 22, 2019 CORRESP

PETQ / PetIQ, Inc. CORRESP - -

CORRESP October 22, 2019 Suying Li Rufus Decker Division of Corporation Finance Office of Beverages, Apparel and Mining United States Securities and Exchange Commission 100 F Street, NE Washington, D.

September 19, 2019 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

Lin UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 19, 2019 PETIQ, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-38163 (Commission File Number) 35

September 19, 2019 EX-99.1

PERRIGO ANIMAL HEALTH ACQUISITION PRO FORMA FINANCIAL INFORMATION SEPTEMBER 19, 2019 2 This presentation contains forward-looking statements that involve risks and uncertainties, such as statements about our plans, objectives, expectations, assumptio

Exhibit 99.1 PERRIGO ANIMAL HEALTH ACQUISITION PRO FORMA FINANCIAL INFORMATION SEPTEMBER 19, 2019 2 This presentation contains forward-looking statements that involve risks and uncertainties, such as statements about our plans, objectives, expectations, assumptions or future events, including statements regarding the potential benefits and synergies of the acquisition of the Perrigo Animal Health

September 19, 2019 EX-99.3

PETIQ, Inc. UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION

PETIQ, Inc. UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION On July 7, 2019, PetIQ, Inc. (the “Company”), through its subsidiary PetIQ, LLC completed the acquisition of all the outstanding stock of Sergeant’s Pet Care Products, Inc. (“Sergeant’s”), dba Perrigo Animal Health, including any assets related to Perrigo Company plc’s animal health business (“Sergeant’s acquisition”). Sergea

September 19, 2019 8-K/A

Financial Statements and Exhibits

Lin UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 7, 2019 PETIQ, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-38163 (Commission File Number) 35-255

September 19, 2019 EX-99.1

ANIMAL HEALTH BUSINESS OF PERRIGO COMPANY PLC COMBINED FINANCIAL STATEMENTS As of and for the years ended December 31, 2018 and 2017; Report of Independent Auditors

ANIMAL HEALTH BUSINESS OF PERRIGO COMPANY PLC COMBINED FINANCIAL STATEMENTS As of and for the years ended December 31, 2018 and 2017; Report of Independent Auditors ANIMAL HEALTH BUSINESS OF PERRIGO COMPANY PLC PAGE NUMBER Report of Independent Auditors 3 Combined Statements of Operations 4 Combined Balance Sheets 5 Combined Statements of Cash Flows 6 Combined Statements of Equity 7 Notes to Combi

September 19, 2019 EX-99.2

ANIMAL HEALTH BUSINESS OF PERRIGO COMPANY PLC CONDENSED COMBINED FINANCIAL STATEMENTS As of March 30, 2019 and December 31, 2018 and for the three months ended March 30, 2019 and March 31, 2018

ANIMAL HEALTH BUSINESS OF PERRIGO COMPANY PLC CONDENSED COMBINED FINANCIAL STATEMENTS (UNAUDITED) As of March 30, 2019 and December 31, 2018 and for the three months ended March 30, 2019 and March 31, 2018 ANIMAL HEALTH BUSINESS OF PERRIGO COMPANY PLC PAGE NUMBER Condensed Combined Statements of Operations 3 Condensed Combined Balance Sheets 4 Condensed Combined Statements of Cash Flows 5 Condense

September 13, 2019 CORRESP

PETQ / PetIQ, Inc. CORRESP - -

CORRESP September 13, 2019 Suying Li Rufus Decker Division of Corporation Finance Office of Beverages, Apparel and Mining United States Securities and Exchange Commission 100 F Street, NE Washington, D.

September 10, 2019 CORRESP

PETQ / PetIQ, Inc. CORRESP - -

CORRESP September 10, 2019 Suying Li Rufus Decker Division of Corporation Finance Office of Beverages, Apparel and Mining United States Securities and Exchange Commission 100 F Street, NE Washington, D.

August 9, 2019 SC 13G

PETQ / PetIQ, Inc. / Alger Associates Inc - SC 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* PetIQ Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 71639T106 (CUSIP Number) July 31, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed

August 8, 2019 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 2, 2019 PETIQ, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-38163 (Commission File Number) 35-2554312

August 8, 2019 EX-10.1

Second Amendment to Amended and Restated Credit Agreement, dated March 25, 2019, by and among PetIQ, LLC, the other credit parties party thereto, the lenders party thereto and East West Bank

Exhibit 10.1 SECOND AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT THIS SECOND AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT (this “Amendment”), dated as of March 25, 2019, is entered into by and among PETIQ, LLC, an Idaho limited liability company (“PetIQ”), the other Credit Parties signatory hereto (collectively with PETIQ, the “Borrowers”), the LENDERS signatory hereto, and EAST WEST B

August 8, 2019 10-Q

PETQ / PetIQ, Inc. 10-Q - Quarterly Report - 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-3

August 7, 2019 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 7, 2019 PETIQ, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-38163 (Commission File Number) 35-2554312

August 7, 2019 EX-99.1

PetIQ, Inc. Reports Record Second Quarter 2019 Financial Results Second Quarter 2019 Net Sales Increased 29% Year-Over-Year to $221 Million Raises Full Year 2019 Outlook for Standalone PetIQ and Provides 2019 Expectations for Perrigo Animal Health Ac

PetIQ, Inc. Reports Record Second Quarter 2019 Financial Results Second Quarter 2019 Net Sales Increased 29% Year-Over-Year to $221 Million Raises Full Year 2019 Outlook for Standalone PetIQ and Provides 2019 Expectations for Perrigo Animal Health Acquisition EAGLE, Idaho – August 7, 2019 – PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today

July 15, 2019 SC 13G/A

PETQ / PetIQ, Inc. / Division of Investment, Department of the Treasury, State of New Jersey - DIVISION OF INVESTMENT, DEPARTMENT OF THE TREASURY,STATE OF NEW JERSEY Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* PETIQ INC (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 71639T106 (CUSIP Number) July 09, 2019 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this

July 9, 2019 EX-10.1

First Amendment to Purchase and Sale Agreement, dated July 7, 2019, by and among PetIQ, LLC, L. Perrigo Company, Perrigo Company plc, and PetIQ, Inc.

EX-10.1 Exhibit 10.1 EXECUTION VERSION FIRST AMENDMENT TO PURCHASE AND SALE AGREEMENT This FIRST AMENDMENT TO PURCHASE AND SALE AGREEMENT (this “Amendment”), dated as of July 7, 2019, is by and among PetIQ, LLC, an Idaho limited liability company (the “Buyer”), L. Perrigo Company, a Michigan corporation (the “Seller”), Perrigo Company plc, an Irish public limited company (the “Seller Parent”), and

July 9, 2019 EX-10.3

Amended and Restructured Term Loan Credit Agreement, dated July 8, 2019, by and among PetIQ, LLC, Ares Capital Corporation and the Lenders party thereto

EX-10.3 Exhibit 10.3 Execution Version FIRST AMENDMENT TO TERM LOAN CREDIT AGREEMENT This FIRST AMENDMENT TO TERM LOAN CREDIT AGREEMENT (this “Amendment”) is dated as of July 8, 2019 and is entered into by and among PETIQ, LLC, an Idaho limited liability company (the “Borrower”), the Guarantors party hereto, ARES CAPITAL CORPORATION and each other Lender party hereto, the Departing Lender (as defi

July 9, 2019 EX-99.1

PetIQ, Inc. Completes Acquisition of Perrigo Animal Health Announces Appointment of Pet and Consumer Packaged Goods Industry Veteran, Michael Smith, as Executive Vice President, Products Division

EX-99.1 Exhibit 99.1 PetIQ, Inc. Completes Acquisition of Perrigo Animal Health Announces Appointment of Pet and Consumer Packaged Goods Industry Veteran, Michael Smith, as Executive Vice President, Products Division EAGLE, Idaho – July 8, 2019 – PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced effective today, it has completed t

July 9, 2019 EX-10.4

Transition Services Agreement, dated July 8, 2019, by and between PetIQ, LLC and L. Perrigo Company

EX-10.4 5 d774928dex104.htm EX-10.4 Exhibit 10.4 Execution Version TRANSITION SERVICES AGREEMENT This TRANSITION SERVICES AGREEMENT (this “Agreement”) is entered into as of July 8, 2019 by and between PetIQ, LLC, an Idaho limited liability company (“Service Recipient”), and L. Perrigo Company, a Michigan corporation (“Service Provider”). Service Recipient and Service Provider are sometimes hereina

July 9, 2019 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 7, 2019 PETIQ, INC. (Exact name of registrant as specified in its charter) Delaware 001-38163 35-2554312 (State or other jurisdiction of incorporation) (Commission File Numbe

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista